1.Scrotal aggressive angiomyxoma mimicking inguinal hernia.
Chia-Chang WU ; Stephen Shei-Dei YANG ; Daniel T H CHIN ; Cheng-Hsing HSIEH ; Yu-Mei HSUEH ; Yao-Chou TSAI
Asian Journal of Andrology 2007;9(5):723-725
Adult
;
Diagnosis, Differential
;
Genital Neoplasms, Male
;
pathology
;
surgery
;
Hernia, Inguinal
;
pathology
;
Humans
;
Male
;
Myxoma
;
pathology
;
surgery
;
Scrotum
;
pathology
2.Hemorrhagic transformation after mechanical thrombectomy for acute ischemic stroke and its effect on prognosis
Yan Zhang ; Xia Zhou ; Youmeng Wang ; Feng Tu ; Juluo Chen ; Mingren Yao ; Zhongwu Sun
Acta Universitatis Medicinalis Anhui 2022;57(6):987-990
Objective:
To explore the hemorrhagic transformation(HT) and its effect on prognosis in patients with acute ischemic stroke(AIS) after mechanical thrombectomy(MT).
Methods:
A total of 114 patients with AIS received MT were enrolled. The modified Rankin Scale was used to evaluate the clinical outcome at 90 days of onset(0-2 points were good prognosis; 3-6 points were poor prognosis). The patients were divided into HT group(n=25) and non-HT group(n=89) according to their HT conditions. Binomial Logistic regression analysis was performed to determine the vascular risk factors of HT after MT and the effect of HT on prognosis.
Results:
Among 114 patients, there were 25 cases of HT and 89 cases of non HT. The proportion of patients with diabetes in HT group was significantly higher than that in non-HT group. The NIHSS score of HT group at discharge was significantly higher than that in non-HT group. The proportion with good prognosis at 90 days in HT group was significantly lower than that in non-HT group(allP<0.05). Binomial Logistic regression analysis showed that diabetes, high levels of cholesterol and smoking were the major vascular risk factors for HT after thrombectomy(allP<0.05). HT was an important factor affecting the poor prognosis after arterial thrombectomy(P=0.026).
Conclusion
Diabetes, high levels of cholesterol and smoking are the main risk factors of HT after MT for AIS. HT is an independent risk factor for poor prognosis after MT.
3.Pathogenesis, progression and treatment of biliary fibrosis
Jinyu ZHAO ; Yanyan LIN ; Ping YUE ; Jia YAO ; Ningning MI ; Matu LI ; Wenkang FU ; Long GAO ; Azumi SUZUKI ; F Peng WONG ; Kiyohito TANAKA ; Rungsun RERKNIMITR ; H Henrik JUNGER ; T Tan CHEUNG ; Emmanuel MELLOUL ; Nicolas DEMARTINES ; W Joseph LEUNG ; Jinqiu YUAN ; J Hans SCHLITT ; Wenbo MENG
Chinese Journal of Digestive Surgery 2024;23(7):989-1000
Biliary fibrosis (BF) is the result of pathological repair of bile tract injury, characterized by thickening and sclerosis of the bile duct wall and progressive stricture of the lumen, which may ultimately lead to serious adverse outcomes such as biliary obstruction, biliary cirrhosis, liver failure, and hepatobiliary malignancies. Current research describes BF as a pathological feature of certain bile tract diseases, lacking a systematic summary of its etiology, pathophysiology, molecular mechanisms, and treatment. BF is a common but easily neglected disease state in biliary system, which may promote the development and progression of hepatobiliary diseases through abnormal repair mechanism after pathological biliary tract injury. Based on the latest research progress from both domestic and international perspectives, the authors review the concept, clinical manifestation, etiology, pathogenesis, and therapeutic strategies of BF to provide a reference for clinical physicians.
4.Asia Pacific Association of Allergy Asthma and Clinical Immunology White Paper 2020 on climate change, air pollution, and biodiversity in Asia-Pacific and impact on allergic diseases
Ruby PAWANKAR ; Jiu Yao WANG ; I Jen WANG ; Francis THIEN ; Yoon Seok CHANG ; Amir Hamzah Abdul LATIFF ; Takao FUJISAWA ; Luo ZHANG ; Bernard Yu Hor THONG ; Pantipa CHATCHATEE ; Ting Fan LEUNG ; Wasu KAMCHAISATIAN ; Iris RENGGANIS ; Ho Joo YOON ; Sonomjamts MUNKHBAYARLAKH ; Marysia T. RECTO ; Anne Goh Eng NEO ; Duy LE PHAM ; Le Thi Tuyet LAN ; Janet Mary DAVIES ; Jae Won OH
Asia Pacific Allergy 2020;10(1):11-
Air pollution, climate change, and reduced biodiversity are major threats to human health with detrimental effects on a variety of chronic noncommunicable diseases in particular respiratory and cardiovascular diseases. The extent of air pollution both outdoor and indoor air pollution and climate change including global warming is increasing-to alarming proportions particularly in the developing world especially rapidly industrializing countries worldwide. In recent years, Asia has experienced rapid economic growth and a deteriorating environment and increase in allergic diseases to epidemic proportions. Air pollutant levels in many Asian countries especially in China and India are substantially higher than are those in developed countries. Moreover, industrial, traffic-related, and household biomass combustion, indoor pollutants from chemicals and tobacco are major sources of air pollutants, with increasing burden on respiratory allergies. Here we highlight the major components of outdoor and indoor air pollutants and their impacts on respiratory allergies associated with asthma and allergic rhinitis in the Asia-Pacific region. With Asia-Pacific comprising more than half of the world's population there is an urgent need to increase public awareness, highlight targets for interventions, public advocacy and a call to action to policy makers to implement policy changes towards reducing air pollution with interventions at a population-based level.
Administrative Personnel
;
Air Pollutants
;
Air Pollution
;
Air Pollution, Indoor
;
Allergy and Immunology
;
Asia
;
Asian Continental Ancestry Group
;
Asthma
;
Biodiversity
;
Biomass
;
Cardiovascular Diseases
;
China
;
Climate Change
;
Climate
;
Consumer Advocacy
;
Developed Countries
;
Economic Development
;
Family Characteristics
;
Global Warming
;
Humans
;
Hypersensitivity
;
India
;
Rhinitis, Allergic
;
Tobacco
5.Related factors and interaction on HIV/HCV co-infection of patients access to methadone maintenance treatment.
T YAO ; D FENG ; M H PAN ; Y P CHENG ; C X LI ; J WANG ; Y L FENG ; J SHI ; T SU ; Q CHEN ; S SHI ; S P WANG
Chinese Journal of Epidemiology 2018;39(5):631-635
Objective: To estimate the prevalence of HIV/HCV co-infection and explore the influence factors and their interaction on HIV/HCV co-infection of patient's access to methadone maintenance treatment (MMT). Methods: A face to face interviews were conducted among 750 patients at two MMT clinics in Guangxi Zhuang Autonomous Region. The questionnaires information included demographic characteristics, HIV and HCV infection status, history of drug abuse, urine test for morphine, high risk sex behaviors, needle sharing, dropped out etc. Methods of χ(2) test one-way, multivariate logistic regression and interactions were used to analyze the related factors of HIV/HCV co-infection. Results: The study subjects included 750 participants, 18.31% (127/691) of patients were co-infected with HIV and HCV. The HIV/HCV co-infection rate in patients who shared needles with others or dropped out of treatment was 35.84% (81/226) and 19.88% (64/322) respectively, which were higher than those who have never shared needles or dropped out (9.89%, 46/465 and 17.07%, 63/369). Logistic regression analysis results showed that after adjusted for confounding factors, patients who shared needles (OR=4.50, 95%CI: 2.72-7.43) and dropped out of treatment (OR=1.71, 95%CI: 1.04-2.80) were more likely to be infected with HIV/HCV. Interaction analysis showed that sharing needles and dropping out of treatment exist additive effect on co-infection of HIV and HCV (RERI=4.21, AP=0.44, SI=1.95). Conclusions: Needle sharing and dropping out of treatment are associated with HIV/HCV co-infection. Health education, psychological counseling and other measures should be taken to reduce needle sharing and dropping out of MMT.
China/epidemiology*
;
Coinfection/epidemiology*
;
Female
;
HIV Infections/epidemiology*
;
Hepatitis C/diagnosis*
;
Humans
;
Logistic Models
;
Male
;
Methadone/therapeutic use*
;
Morphine
;
Needle Sharing
;
Opiate Substitution Treatment
;
Prevalence
;
Risk Factors
;
Sexual Behavior
;
Substance Abuse, Intravenous/drug therapy*
;
Substance-Related Disorders
6.HIV gene subtypes of newly reported HIV/AIDS cases in Dehong Dai and Jingpo autonomous prefecture of Yunnan province, 2016.
X DUAN ; K R WANG ; J B WANG ; R H YE ; Y K WANG ; J YANG ; T YANG ; S J ZHOU ; Y C YANG ; S T YAO ; S DUAN ; N HE
Chinese Journal of Epidemiology 2018;39(5):678-681
Objective: To explore distribution of HIV gene subtypes among newly reported HIV/AIDS cases from China and Myanmar in Dehong Dai and Jingpo prefecture of Yunnan province in 2016. Methods: We conducted DNA extractions from newly reported HIV/AIDS cases in 2016. The gag, env and pol genes were amplified by using reverse transcription-PCR (RT-PCR) and sequenced to identify HIV subtypes. Results: A total of 1 112 newly diagnosed HIV cases were reported in Dehong in 2016, and the HIV subtypes were identified for 860 cases. Subtype C was predominant (33.6%), followed by unique recombinant forms (URFs) (28.4%), CRF01_AE (18.6%) and so on. URFs include four recombination, among which the recombination of CRF01_AE and C subtype were predominant. The HIV subtype distribution was associated with nationality and transmission route in HIV/AIDS cases from Myanmar. Conclusions: The gene subtypes of C, URFs and CRF01_AE were mainly distributed; distribution of URFs remained complex and diverse among newly reported HIV/AIDS cases in Dehong in 2016.
Base Sequence
;
China/epidemiology*
;
Ethnicity/genetics*
;
Genes, pol
;
Genotype
;
HIV Infections/genetics*
;
HIV-1/genetics*
;
Humans
;
Male
;
Phylogeny
;
Polymerase Chain Reaction/methods*
;
Serogroup
7.Molecular transmission clusters on HCV genotypes among newly reported HIV/HCV co-infection in Dehong Dai and Jingpo autonomous prefecture of Yunnan province, 2016.
Y K WANG ; X C CHEN ; J B WANG ; X DUAN ; S J ZHOU ; J YANG ; T YANG ; R H YE ; Y C YANG ; S T YAO ; S DUAN ; N HE
Chinese Journal of Epidemiology 2019;40(2):191-195
Objective: To understand the characteristics on major strain subtypes of hepatitis C virus among HIV/HCV co-infected patients, so as to explore the molecular transmission clusters and related risk factors of HCV strains. Methods: A total of 336 newly reported HIV-infected patients were diagnosed as HIV/HCV co-infection in Dehong Dai and Jingpo autonomous prefecture (Dehong) in 2016. We used Nested PCR to amplify CE1 and NS5B genes among 318 samples with plasma levels above 200 μl, before using the combining phylogenetic tree and constructing molecular propagation network method to analyze the related data. Results: A total of 267 HIV/HCV co-infection patients who had met the HCV genotyping requirements were screened the gene subtypes were diversified. Among these genotypes, proportions of 3b, 6n, 6u, 1a, 3a and other subtypes appeared as 32.6% (87/267), 18.4% (49/267), 15.7%(42/267), 13.1%(35/267), 11.2%(30/267) and 9.0%(24/267) respectively. Molecular transmission network of five major HCV genotypes was constructed with a clustering rate of 39.1% (95/243). The clustering rate of subtype 1a was the highest, as 71.4% (25/35). Results from the multivariate logistic regression showed that ethnic minorities other than the Yi and Jingpo (vs. the Han, OR=0.17, 95%CI: 0.04-0.71), the married spouses (vs. the unmarried, OR=0.42, 95%CI: 0.18-0.94), the 6n and 3a subtype (vs. the 3b subtype, OR=0.34, 95%CI: 0.12-0.95; OR=0.22, 95%CI: 0.05-0.93) were more difficult to form transmission clusters. However, the 6u and 1a subtype (vs. the 3b subtype, OR=3.10, 95%CI: 1.21-7.94; OR=4.00, 95%CI: 1.32-12.11) seemed more likely to form the transmission clusters. Conclusion: Ethnicity, marital status and genetic subtypes were factors significantly associated with the formation of transmission clusters related to the major HCV gene subtypes among newly reported HIV/HCV co-infection in Dehong.
AIDS-Related Opportunistic Infections/virology*
;
Asian People
;
China/epidemiology*
;
Coinfection
;
Genotype
;
HIV Infections/virology*
;
Hepacivirus/isolation & purification*
;
Hepatitis C/virology*
;
Humans
;
Phylogeny
;
Polymerase Chain Reaction
8.Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Philippines: Results from the Dyslipidemia international study II
Rody G. Sy ; Maria Teresa B. Abola ; Baishali Ambegaonkar ; Roy Joseph M. Barcinas ; Philippe Brudi ; Martin Horack ; Dominik Lautsch ; Aurora G. Macaballug ; Eugenio B. Reyes ; Noel L. Rosas ; Domingo P. Solimen ; Ami Vyas ; Christy S. Yao ; Maria Delfa T. Zanoria ; Anselm K. Gitt
Acta Medica Philippina 2018;52(61):494-501
Objective:
To quantify the extent of hyperlipidemia and its treatment in patients with stable coronary heart disease (CHD) or an acute coronary syndrome (ACS) in the Philippines.
Methods:
The Dyslipidemia International Study (DYSIS) II was an observational, multinational study conducted in patients aged ≥18 years with stable CHD or being hospitalized with an ACS. A full lipid profile was evaluated at baseline, and for the ACS cohort, at 4 months after discharge from hospital. Achievement of low-density lipoprotein cholesterol (LDL-C) targets and the use of lipid-lowering therapy (LLT) were assessed.
Results:
A total of 232 patients were enrolled from 10 centers in the Philippines, 184 with stable CHD and 48 being hospitalized with an ACS. The mean LDL-C level for the CHD patients was 88.0±40.1 mg/dL, with 33.3% achieving the target of <70 mg/dL recommended for very high-risk patients. For the ACS cohort, the mean LDL-C level was 109.0±48.5 mg/dL, with target attainment of 25.0%. The majority of the CHD cohort was being treated with LLT (97.3%), while 55.3% of the ACS patients were receiving LLT prior to hospitalization, rising to 100.0% at follow-up. There was little use of non-statins.
Conclusions
For these very high-risk patients from the Philippines, LDL-C target attainment was poor. Opportunities for better monitoring and treatment of these subjects are being missed.
Cholesterol
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Coronary Disease
;
Acute Coronary Syndrome
;
Myocardial Infarction
10.Metabolic syndrome increases Framingham risk score of patients with type 2 diabetes mellitus.
Yao MEIFANG ; Sun XUE ; Han JUE ; T U YINA ; H E JIE ; Zhao YIMING ; Lou HANYU ; Pang XIAOHONG ; Zeng WENHENG ; Zhang SONGZHAO ; Shan PENGFEI
Journal of Zhejiang University. Medical sciences 2016;45(3):268-274
OBJECTIVETo assess the impact of metabolic syndrome(MS) on Framingham risk score(FRS) in patients with type 2 diabetes mellitus (T2DM).
METHODSThe anthropometric and biochemical data of 1708 patients with T2DM admitted in hospital from May 2008 to April 2013 were retrospectively analyzed, including 902 males and 806 females with a mean age of 57.1±11.8 years (20-79 years). Diagnosis of MS was made according to the criteria of the Adult Treatment Panel Ⅲ Criteria modified for Asians.
RESULTSCompared to non-MS/T2DM patients, MS/T2DM patients had higher waist circumference, body weight, body mass index, systolic and diastolic blood pressure, fasting C peptide, total cholesterol, triglyceride, and LDL-C (P<0.05), while lower HDL-C (P<0.01). Both FRS [13.0(10.0, 15.0) vs 11.0(9.0, 13.0) in male,15.0(12.0, 18.0) vs 12.0(6.0, 14.8) in female,P<0.01)] and 10-year cardiovascular risk [12.0%(6.0%, 20.0%) vs 8.0%(5.0%,12.0%) in male,3.0%(1.0%, 6.0%) vs 1.0%(0.0%, 2.8%) in female,P<0.01] were higher in MS/T2DM patients than those in non-MS/T2DM patients.Both FRS and 10-year cardiovascular risk were increased with the components of MS.
CONCLUSIONT2DM patients with MS have more cardiovascular risk factors, higher FRS and 10-year cardiovascular risk.